Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,178 | $5,863 | $4,126 | $1,921 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $9,178 | $5,863 | $4,126 | $1,921 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,756 | $1,425 | $1,419 | $265 |
| SG&A Expenses | $1,756 | $1,425 | $1,419 | $265 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,389 | $4,705 | $3,316 | $2,226 |
| Operating Expenses | $9,145 | $6,130 | $4,736 | $2,492 |
| Operating Income | $33 | -$267 | -$610 | -$571 |
| % Margin | 0.4% | -4.6% | -14.8% | -29.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $33 | -$267 | -$610 | -$571 |
| Tax Expense | $7 | $3 | -$1 | $1 |
| Net Income | $25 | -$271 | -$606 | -$573 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS | 0.11 | -1.22 | -2.87 | -3.19 |
| % Growth | 109% | 57.5% | 10% | – |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| Weighted Avg Shares Out | 240 | 222 | 212 | 179 |
| Weighted Avg Shares Out Dil | 266 | 222 | 212 | 179 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $24 | $25 | $23 | $5 |
| Depreciation & Amortization | $32 | $31 | $15 | $15 |
| EBITDA | $89 | -$212 | -$572 | -$551 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |